Hydrostatic isolated limb perfusion with adeno-associated virus vectors enhances correction of skeletal muscle in Pompe disease.

dc.contributor.author

Sun, B

dc.contributor.author

Li, S

dc.contributor.author

Bird, A

dc.contributor.author

Koeberl, DD

dc.coverage.spatial

England

dc.date.accessioned

2017-03-01T14:20:26Z

dc.date.available

2017-03-01T14:20:26Z

dc.date.issued

2010-12

dc.description.abstract

Glycogen storage disease type II (Pompe disease; MIM 232300) stems from the inherited deficiency of acid-α-glucosidase (GAA; acid maltase; EC 3.2.1.20), which primarily involves cardiac and skeletal muscles. We hypothesized that hydrostatic isolated limb perfusion (ILP) administration of an adeno-associated virus (AAV) vector containing a muscle-specific promoter could achieve relatively higher transgene expression in the hindlimb muscles of GAA-knockout (GAA-KO) mice, in comparison with intravenous (IV) administration. ILP administration of AAV2/8 vectors encoding alkaline phosphatase or human GAA-transduced skeletal muscles of the hindlimb widely, despite the relatively low number of vector particles administered (1 × 10¹¹), and IV administration of an equivalent vector dose failed to transduce skeletal muscle detectably. Similarly, ILP administration of fewer vector particles of the AAV2/9 vector encoding human GAA (3 × 10¹⁰) transduced skeletal muscles of the hindlimb widely and significantly reduced glycogen content to, in comparison with IV administration. The only advantage for IV administration was moderately high-level transduction of cardiac muscle, which demonstrated compellingly that ILP administration sequestered vector particles within the perfused limb. Reduction of glycogen storage in the extensor digitorum longus demonstrated the potential advantage of ILP-mediated delivery of AAV vectors in Pompe disease, because type II myofibers are resistant to enzyme replacement therapy. Thus, ILP will enhance AAV transduction of multiple skeletal muscles while reducing the required dosages in terms of vector particle numbers.

dc.identifier

https://www.ncbi.nlm.nih.gov/pubmed/20686508

dc.identifier

gt2010109

dc.identifier.eissn

1476-5462

dc.identifier.uri

https://hdl.handle.net/10161/13714

dc.language

eng

dc.publisher

Springer Science and Business Media LLC

dc.relation.ispartof

Gene Ther

dc.relation.isversionof

10.1038/gt.2010.109

dc.subject

Animals

dc.subject

Dependovirus

dc.subject

Disease Models, Animal

dc.subject

Genetic Therapy

dc.subject

Genetic Vectors

dc.subject

Glycogen Storage Disease Type II

dc.subject

HEK293 Cells

dc.subject

Hindlimb

dc.subject

Humans

dc.subject

Infusions, Intravenous

dc.subject

Mice

dc.subject

Mice, Inbred C57BL

dc.subject

Mice, Knockout

dc.subject

Muscle, Skeletal

dc.subject

Perfusion

dc.subject

Promoter Regions, Genetic

dc.title

Hydrostatic isolated limb perfusion with adeno-associated virus vectors enhances correction of skeletal muscle in Pompe disease.

dc.type

Journal article

duke.contributor.orcid

Sun, B|0000-0002-2191-0025

duke.contributor.orcid

Koeberl, DD|0000-0003-4513-2464

pubs.author-url

https://www.ncbi.nlm.nih.gov/pubmed/20686508

pubs.begin-page

1500

pubs.end-page

1505

pubs.issue

12

pubs.organisational-group

Basic Science Departments

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Duke

pubs.organisational-group

Molecular Genetics and Microbiology

pubs.organisational-group

Pediatrics

pubs.organisational-group

Pediatrics, Medical Genetics

pubs.organisational-group

School of Medicine

pubs.publication-status

Published

pubs.volume

17

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Hydrostatic isolated limb perfusion with adeno-associated virus vectors enhances correction of skeletal muscle in Pompe disease.pdf
Size:
1023.15 KB
Format:
Adobe Portable Document Format